Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase

European Journal of Pharmacology

Volumn 342, Issue 2-3, 1998, Pages 217-224

  Jing, Ming ^a   Ling, Geoffrey S F ^a   Bina, Saiid ^a   Hart, Jayne L ^b   Muldoon, Sheila M ^a  

^a University of Health Sciences   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

Author keywords

Guanylyl cyclase inhibitor, soluble; Guanylyl cyclase, soluble; Halothane; LY 83583; Methylene blue; Nitric oxide (NO); Nitroglycerin; Relaxation; Smooth muscle, vascular, rat

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; HALOTHANE; METHYLENE BLUE; NITRIC OXIDE; RECEPTOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG MIXTURE; ENZYME ACTIVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASODILATATION;

AMINOQUINOLINES; ANESTHETICS, INHALATION; ANIMALS; AORTA, THORACIC; BINDING, COMPETITIVE; CYCLIC GMP; ENZYME INHIBITORS; GUANYLATE CYCLASE; HALOTHANE; MALE; METHYLENE BLUE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROGLYCERIN; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 0032567708     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01491-X     Document Type: Article

References (31)

1. Baker M.T., Nelson R.N., Van Dyke R.A. The release of inorganic fluoride from halothane and halothane derivative by cytochrome P-450, hemin, and hemoglobin. Drug Metab. Dispos. 11:1983;303-311.
2. Barbier A.J.M., Lefebvre R.A. Effect of LY 83583 on relaxation induced by non-adrenergic non-cholinergic nerve stimulation and exogenous nitric oxide in rat gastric fundus. Eur. J. Pharmacol. 219:1992;331-334.
3. Brandt M.A., Conrad K.P. In vivo and in vitro studies of a putative inhibitor of cyclic guanosine 3′,5′-monophosphate production. Proc. Soc. Exp. Bio. Med. 196:1991;30-35.
4. Craven P.A., De Rubertis F.R. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. J. Biol. Chem. 253:1978;8433-8443.
5. Diamond J. Effect of quinacrine, NDGA and LY 83583 on acetylcholine induced elevation of cyclic GMP and relaxation of rabbit aortic rings. Proc. West. Pharmacol. Soc. 29:1986;105-109.
6. Furchgott R.F., Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 3:1989;2007-2017.
7. Gillespie J.S., Sheng H. Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle. Br. J. Pharmacol. 95:1988;1151-1156.
8. Gillespie J.S., Sheng H. The effect of pyrogallol and hydroquinone on the response to NANC nerve stimulation in the rat anococcygeus and the bovine retractor penis muscle. Br. J. Pharmacol. 99:1990;194-196.
9. Gruetter C.A., Kadowitz P.J., Ignarro L.J. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can. J. Physiol. Pharmacol. 59:1981;150-156.
10. Hart J.L., Jing M., Bina S., Freas W., Van Dyke R.A., Muldoon S.M. Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations. Anesthesiology. 79:1993;323-331.
11. Hobbs A.J., Tucker J.F., Gibson A. Differentiation by hydroquinone of relaxation induced by exogenous and endogenous nitrates in-vascular smooth muscle: Role of superoxide anion. Br. J. Pharmacol. 104:1991;645-650.
12. Ignarro L.J. Regulation of cytosolic guanylyl cyclase by prophyrins and metalloporphyrins. Adv. Pharmacol. 26:1994;35-47.
13. Jing M., Hart J.L., Masaki E., Bina S., Muldoon S.M. Vascular effects of halothane and isoflurane: cGMP dependent and independent actions. Life Sci. 56:1995;19-29.
14. Jing M., Hart J.L., Verma A., Bina S., Muldoon S.M. Effects of halothane and isoflurane on carbon monoxide induced relaxation in the rat aorta. Anesthesiology. 85:1996;347-354.
15. Kawada T., Ishibashi T., Sasage H., Kato K., Imai S. Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atripeptin in aortae of the rat, guinea-pig and rabbit. Gen. Pharmacol. 25:1994;1361-1371.
16. Kelner M.J., Bagnell R., Hale B., Alexander N.M. Methylene blue competes with paraquat for reduction by flavo-enzymes resulting in decreased superoxide production in the presence of heme proteins. Arch. Biochem. Biophys. 262:1988;422-426.
17. Malta E. Biphasic relaxant curve to glyceryl trinitrate in rat aortic rings. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;236-243.
18. Malta E., Macdonald P.S., Dusting G.J. Effect of LY 83583 on relaxant responses and levels of cyclic cGMP in rat aorta. Blood Vessels. 24:1987;213-218.
19. Martin W., Villani G.M., Jothianandan D., Furchgott R.F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232:1985;708-716.
20. Masters B.S., McMillan K., Sheta E.A., Nishimura J.S., Roman L.J., Martasek P. Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: Structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO as a cellular signal. FASEB J. 10:1996;552-558.
21. Mayer B., Brunner F., Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol. 45:1993;367-374.
22. Muldoon S.M., Hart J.L., Bowen K.A., Freas W. Attenuation of endothelium-mediated vasodilation by halothane. Anesthesiology. 67:1988;31-37.
23. Mülsch A., Busse R., Liebauand S., Förstermann U. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharmacol. Exp. Ther. 247:1988;283-288.
24. Nakamura K., Terasako K., Toda H., Miyawaki I., Kakuyama M., Nishiwada M., Hatano Y., Mori K. Mechanisms of inhibition of endothelium-dependent relaxation by halothane, isoflurane, and sevoflurane. Can. J. Anaesth. 41:1994;340-346.
25. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
26. Rajanayagam M.A.S., Li C.G., Rand M.J. Differential effects of hydroxocobalammin on NO-mediated relaxation in rat aorta and anococcygeus muscle. Br. J. Pharmacol. 108:1993;3-5.
27. Rengasamy A., Ravichandran L.V., Reikersdorfer C.G., Johns R.A. Inhalational anesthetics do not alter nitric oxide synthase activity. J. Pharmacol. Exp. Ther. 273:1995;599-604.
28. Stone D.J., Johns R.A. Endothelium-dependent effects of halothane, enflurane and isoflurane on rat aortic vascular rings. Anesthesiology. 71:1989;126-132.
29. Toda H., Nakamura K., Hatano Y., Nishiwada M., Kakuyama M., Mori K. Halothane and isoflurane inhibit endothelium-dependent relaxation elicited by acetylcholine. Anesth. Analg. 75:1992;198-203.
30. Torfgård K., Ahlner J., Axelsson K.L. Relaxation of bovine mesenteric arteries by glyceryl trinitrate and other nitro-compounds: Evidence for partly different mechanisms of action. Pharmacol. Toxicol. 67:1990;216-221.
31. Uggeri M.J., Proctor G.J., Johns R.A. Halothane, enflurane, and isoflurane attenuate both receptor- and non-receptor-mediated EDRF production in rat aorta. Anesthesiology. 76:1992;1012-1017.